Quoin Pharmaceuticals Ltd. (QNRX) Net income 2019–2025
Quoin Pharmaceuticals Ltd. (QNRX) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$15.8MFY2025 · since FY2019: -$1.6M → -$15.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.8M | -76.3% |
| FY2024 | -$9.0M | -3.2% |
| FY2023 | -$8.7M | +7.4% |
| FY2022 | -$9.4M | +56.3% |
| FY2021 | -$21.5M | -924.3% |
| FY2020 | -$2.1M | -34.3% |
| FY2019 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More QNRX financial trends
QNRX RevenueQNRX Net marginQNRX Gross profitQNRX Gross marginQNRX Operating incomeQNRX Operating marginQNRX Operating cash flowQNRX Free cash flowQNRX Capital expendituresQNRX Return on equityQNRX Stock buybacksQNRX Dividends paidQNRX Total assetsQNRX Total liabilitiesQNRX Shareholders’ equityQNRX overview →